Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Polaris begins enrollment in phase II trial of ADI-PEG 20 in malignant mesothelioma

March 21, 2011

CHMP adopts negative opinion for Vectibix in combination with chemotherapy

March 21, 2011

Nerviano enters into oncology license agreement with Novartis

March 21, 2011

New B-raf inhibitors reported by Array BioPharma and Genentech

March 21, 2011

SPINK1 identified as potential therapeutic target in prostate cancer

March 21, 2011

Phase I trial of AZD-8055 in subjects with recurrent gliomas to begin this month

March 18, 2011

Antisense Therapeutics continues seeking partner for ATL-1101 in prostate cancer

March 18, 2011

Senesco's study of SNS01-T in multiple myeloma on hold by FDA

March 18, 2011

Ariad and Merck & Co. to copromote ridaforolimus for sarcoma in U.S.

March 18, 2011

CytRx begins phase Ib INNO-206 study in advanced solid tumors

March 18, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Kymera’s IRF5 degrader shows potential in IBD treatment
BioWorld Science
At the recently concluded Digestive Disease Week, researchers from Kymera Therapeutics Inc. presented preclinical efficacy data on KT-579, a selective oral IRF5...